WHO declares updates to forthcoming guidance on systematic screening for TB

NewsGuard 100/100 Score

In a Rapid Communication issued today, the World Health Organization (WHO) is announcing a number of updates to its forthcoming guidance on the systematic screening of tuberculosis (TB) disease. This will help national TB programmes, public and private healthcare providers, funders and other stakeholders to prepare for the changes that will be introduced when the new guidelines are released in early 2021.

Close to three million people with TB are estimated not to be diagnosed or reported annually around the world. Improved TB screening using new tools and approaches to reach all people with care could help bridge this gap. Measures like screening need to be stepped up rapidly to reach the global target of treating at least 40 million people with TB by 2022.

The updated guidance will avail of the latest evidence and best available practices on, amongst others, new approaches to screening of people at risk, the role of new technologies such as computer-aided detection (CAD) to interpret chest radiography and the use of molecular rapid diagnostics for screening.

Systematic screening is critical to ensure we can detect TB early in the people who need it, while also identifying people who could benefit from TB preventive treatment. This is important to break the chain of transmission and to ensure no one is left behind. We need to maximize upon the synergies between the delivery of TB and COVID services during contact investigation and other situations, especially at these times of crisis when the demand on healthcare services is high."

Dr Tereza Kasaeva, Director, WHO's Global TB Programme

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
WHO releases an investment case for TB screening and preventive treatment